Which leukemia has poor prognosis

Chronic Myeloid Leukemia

Chronic myeloid leukemia (CML) is a type of cancer that affects the white blood cells in the bone marrow, and it typically has a poor prognosis. CML is often diagnosed in adults over the age of 60, but it can also affect younger people. CML is caused by a mutation in the white blood cells, which causes them to grow and divide uncontrollably. Treatment for CML usually involves chemotherapy, radiation, and/or targeted drug therapies, but the disease is difficult to cure.

Acute Lymphoblastic Leukemia

Acute lymphoblastic leukemia (ALL) is a type of cancer that affects the white blood cells in the bone marrow. It is the most common type of childhood leukemia, and it can also affect adults. ALL is caused by a mutation in the white blood cells, which causes them to grow and divide uncontrollably. Treatment for ALL usually involves chemotherapy and radiation, but the long-term outlook is not good. Although some people can achieve remission, the cancer usually returns and is difficult to treat.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a type of cancer that affects the white blood cells in the bone marrow. It is a fast-growing cancer that can spread quickly to other parts of the body. Treatment for AML usually involves chemotherapy and radiation, but the long-term outlook is not good. Although some people can achieve remission, the cancer usually returns and is difficult to treat.

Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the white blood cells in the bone marrow. It is typically diagnosed in adults over the age of 60, but it can also affect younger people. CLL is caused by a mutation in the white blood cells, which causes them to grow and divide uncontrollably. Treatment for CLL usually involves chemotherapy, radiation, and/or targeted drug therapies, but the disease is difficult to cure.

Which leukemia has poor prognosis?

Unfortunately, all types of leukemia have a poor prognosis. Acute myeloid leukemia (AML) is one of the most aggressive, with a five-year survival rate of only 24%. Acute lymphoblastic leukemia (ALL) has a slightly better prognosis, with a five-year survival rate of 38%. Chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) have the most favorable prognosis, with five-year survival rates of 68% and 65%, respectively. However, prognosis can vary greatly depending on age, type of leukemia, and other factors.

Acute myeloid leukemia (AML) typically has a poorer prognosis than other types of leukemia, such as acute lymphoblastic leukemia (ALL). Survival rates for AML vary depending on age and other factors, but overall it is associated with a lower chance of remission and cure.